Immunology and immunotherapy approaches for prostate cancer.
about
Combination immunotherapy with 4-1BBL and CTLA-4 blockade for the treatment of prostate cancerCell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancerSPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.In silico functional profiling of individual prostate cancer tumors: many genes, few functions.Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.
P2860
Immunology and immunotherapy approaches for prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immunology and immunotherapy approaches for prostate cancer.
@en
type
label
Immunology and immunotherapy approaches for prostate cancer.
@en
prefLabel
Immunology and immunotherapy approaches for prostate cancer.
@en
P2860
P356
P1476
Immunology and immunotherapy approaches for prostate cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.PCAN.4500964
P50
P577
2007-04-10T00:00:00Z